Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test

Abstract

Cognitive impairment is common in multiple sclerosis (MS), yet difficult to detect duringroutine neurologic examination. Therefore, briefscreening tests that identify patients who may benefit from a more thorough assessment or treatment are needed. We investigated the utility of the Symbol Digit Modalities Test (SDMT) as a screen for cognitive dysfunction because it can be administered and scored in about 5 minutes. One hundred MS patients and 50 healthy controls, matched on demographic variables, participated in the study. Examination procedures included the neuropsychological (NP) tests included in the Minimal Assessment of Cognitive Function in MS (MACFIMS) battery. Patients were considered impaired if they performed one and a half standard deviations below controls on two or more MACFIMS variables, excluding theSDMT. Bayesian statistics showed that a total score of 55 or lower onthe SDMT accurately categorized 72% of patients, yielding sensitivityof 0.82, specificity of 0.60, positive predictive value (PPV) of 0.71, and negative predictive value (NPV) of 0.73. These results suggest that the effectiveness of the SDMT as a screen for cognitive impairment in MS is roughly equal to that of other psychometric and questionnaire methods.

Keywords

cognition neuropsychology processing speed psychological speed screening

Get full access to this article

View all access options for this article.

References

Rao SM , Leo GJ , Bernardin L , Unverzagt F. Cognitive dysfunction in multiple sclerosis I: Frequency, patterns, and predictions . Neurology 1991; 41: 685–691 .

Amato MP , Ponziani G , Pracucci G , Bracco L , Siracusa G , Amaducci L. Cognitive impairment in early onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up . Arch Neurol 1995; 52: 168–172 .

Heaton RK , Nelson LM , Thompson DS , Burks JS , Franklin GM. Neuropsychological findingsin relapsing-remitting and chronic-progressive multiple sclerosis . J Consult Clin Psychology 1985; 53: 103–110 .

Beatty WW , Blanco CR , Wilbanks SL , Paul RH. Demographic, clinical, and cognitive characteristics of multiple sclerosis patients who continue to work . J Neurol Rehabil 1995; 9: 173–173 .

Rao SM , Leo GJ , Ellington L , Nauertz T , Bernardin L , Unverzagt F. Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning . Neurology 1991; 41: 692–696 .

Rao SM , Leo GJ , Haughton VM , Aubin-Faubert PS , Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis . Neurology 1989; 39: 161–166 .

Higginson CI , Arnett PA , Voss WD. The ecological validity of clinical tests of memory and attention in multiple sclerosis . Arch Clin Neuropsychol 2000; 15: 185–204 .

Fischer JS. Objective memory testing in multiple sclerosis. In Jensen K , Knudsen L , Stenager E , Grant I eds. Mental disorders and cognitive deficits in multiple sclerosis. John Libbey , 1989: 39–49.

Fischer JS , Foley FW , Aikens JE , Ericson GD , Rao SM , Shindell S.

What do we really know about cognitive dysfunction, affective disorders, and stress in multiple sclerosis?

J Neurol Rehab 1994; 8: 151–164 .

10.

Peyser JM , Edwards KR , Poser CM , Filskov SB. Cognitive function in patients with multiple sclerosis . Arch Neurol 1980; 37: 577–579 .

11.

Benedict RHB , Munschauer F , Linn R , Miller C , Murphy E , Foley F et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire . Mult Scler 2003; 9: 95–101 .

12.

Benedict RHB . Integrating cognitive function screening and assessment into the routine care of multiple sclerosis patients . CNS Spec 2005; 10: 384–391 .

13.

Basso MR , Beason-Hazen S , Lynn J , Rammohan K , Bornstein RA. Screening for cognitive dysfunction in multiple sclerosis . Arch Neurol 1996; 53: 980–984 .

14.

Beatty WW , Paul RH , Wilbanks SL , Hames KA , Blanco CR , Goodkin DE. Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI) . Neurology 1995; 45: 718–723 .

15.

Franklin GM , Heaton RK , Nelson LM , Filley CM , Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis . Neurology 1988; 38: 1826–1829 .

16.

Benedict RHB , Cox D , Thompson LL , Foley F , Weinstock-Guttman B , Munschaeur F. Reliable screening for neuropsychological impairment in multiple sclerosis . Mult Scler 2004; 10: 675–678 .

17.

Benedict RHB , Fischer J , Archibald CJ , Arnett P , Beatty WW , Bobholz J et al. Minimal neuropsychological assessment of MS patients: a consensus approach . Clin Neuropsychol 2002; 16: 381–397 .

18.

Benedict RHB , Bakshi R , Simon JH , Priore R , Miller C , Munschaeur F. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis . J Neuropsychiatry Clin Neurosci 2002; 14: 44–51 .

19.

Benedict RHB , Weinstock-Guttman B , Fishman I , Sharma J , Tjoa CW , Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis . Arch Neurol 2004; 61: 226–230 .

20.

Christodoulou C , Krupp LB , Liang Z , Huang W , Melville P , Rogne C et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients . Neurology 2003; 60: 1793–1798 .

21.

McDonald WI , Compston A , Edan G , Goodkin D , Hartung HP , Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121–127 .

22.

Kurtzke J. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS) . Ann Neurol 1983; 13: 227–231 .

23.

Benton AL , Sivan AB , Hamsher K , Varney NR , Spreen O. Contributions to neuropsychological assessment, second edition. Oxford University Press , 1994.

24.

Benton AL , Hamsher K. Multilingual aphasia examination. AJA Associates , 1989.

25.

Delis DC , Kramer JH , Kaplan E , Ober BA. California Verbal Learning Test manual: second edition (Adult version). Psychological Corporation , 2000.

26.

Benedict RHB Brief Visuospatial Memory Test – revised: professional manual. Psychological Assessment Resources , 1997.

27.

Delis DC , Kaplan E , Kramer JH. Delis – Kaplan Executive Function System (DKEFS): examiner's manual. The Psychological Corporation , 2001.

28.

Beck AT , Steer RA , Brown GK. BDI-fast screen for medical patients: manual. Psychological Corporation , 2000.

29.

Benedict RHB , Fishman I , McClellan MM , Bakshi R , Weinstock-Guttman B. Validity of the Beck Depression Inventory – fast screen in multiple sclerosis . Mult Scler 2003; 9: 393–396 .

30.

Rao SM. Neuropsychological screening battery for multiple sclerosis. 1991. Ref Type: Unpublished Work.

31.

Fischer JS , Rudick RA , Cutter GR , Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force . Mult Scler 1999; 5: 244–250 .

32.

DeLuca J , Chelune GJ , Tulsky DS , Lengenfelder J , Chiaravalloti ND.

Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?

J Clin Exp Neuropsychol 2004; 26: 550–562 .

33.

Demaree HA , DeLuca J , Gaudino EA , Diamond BJ. Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation . J Neurol NeurosurgPsychiatry 1999; 67: 661–663 .

34.

Kail R. Speed of information processing in patients with multiple sclerosis . J Clin Exp Neuropsychol 1998; 20: 98–106 .

35.

Benedict RHB Effects of using same-versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis . J Int Neuropsychol Soc 2005; 11: 727–736 .

36.

Benedict RHB , Cookfair DL , Gavett R , Gunther M , Munschaker F , Garg N et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) Battery. J Int Neuropsychol Soc. 2006; in press.